HomeME • NASDAQ
add
23andMe Holding Co.
Previous close
$0.50
Year range
$0.35 - $2.21
Market cap
242.67M USD
Avg Volume
6.61M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 44.75M | -33.15% |
Operating expense | 100.85M | -14.34% |
Net income | -277.98M | -202.28% |
Net profit margin | -621.22 | -352.19% |
Earnings per share | — | — |
EBITDA | -75.46M | 4.25% |
Effective tax rate | -0.01% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 242.42M | -43.99% |
Total assets | 608.21M | -40.64% |
Total liabilities | 231.02M | -15.58% |
Total equity | 377.19M | — |
Shares outstanding | 482.92M | — |
Price to book | 0.64 | — |
Return on assets | -28.70% | — |
Return on capital | -34.81% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -277.98M | -202.28% |
Cash from operations | -12.06M | -147.21% |
Cash from investing | -2.01M | 34.38% |
Cash from financing | 105.00K | 1,054.55% |
Net change in cash | -13.97M | -164.34% |
Free cash flow | -2.60M | -104.31% |
About
23andMe Holding Co. is a publicly traded personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Founded
Apr 2006
Headquarters
Website
Employees
758